These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 22532493)

  • 1. Histological differentiation grade and microvascular invasion of hepatocellular carcinoma predicted by dynamic contrast-enhanced MRI.
    Witjes CD; Willemssen FE; Verheij J; van der Veer SJ; Hansen BE; Verhoef C; de Man RA; Ijzermans JN
    J Magn Reson Imaging; 2012 Sep; 36(3):641-7. PubMed ID: 22532493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imaging features of small hepatocellular carcinomas with microvascular invasion on gadoxetic acid-enhanced MR imaging.
    Kim MJ; Lee M; Choi JY; Park YN
    Eur J Radiol; 2012 Oct; 81(10):2507-12. PubMed ID: 22137613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of microvascular invasion of hepatocellular carcinoma: usefulness of peritumoral hypointensity seen on gadoxetate disodium-enhanced hepatobiliary phase images.
    Kim KA; Kim MJ; Jeon HM; Kim KS; Choi JS; Ahn SH; Cha SJ; Chung YE
    J Magn Reson Imaging; 2012 Mar; 35(3):629-34. PubMed ID: 22069244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging predicts the histological grade of hepatocellular carcinoma only in patients with Child-Pugh class A cirrhosis.
    Kim HY; Choi JY; Kim CW; Bae SH; Yoon SK; Lee YJ; Rha SE; You YK; Kim DG; Jung ES
    Liver Transpl; 2012 Jul; 18(7):850-7. PubMed ID: 22407909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contribution of diffusion-weighted magnetic resonance imaging in the characterization of hepatocellular carcinomas and dysplastic nodules in cirrhotic liver.
    Xu PJ; Yan FH; Wang JH; Shan Y; Ji Y; Chen CZ
    J Comput Assist Tomogr; 2010 Jul; 34(4):506-12. PubMed ID: 20657216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microvascular invasion in hepatocellular carcinoma: is it predictable with pretransplant MRI?
    Chandarana H; Robinson E; Hajdu CH; Drozhinin L; Babb JS; Taouli B
    AJR Am J Roentgenol; 2011 May; 196(5):1083-9. PubMed ID: 21512074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancement pattern analysis of hypervascular hepatocellular carcinoma on dynamic MR imaging with histopathological correlation: validity of portal phase imaging for predicting tumor grade.
    Okamoto D; Yoshimitsu K; Nishie A; Tajima T; Asayama Y; Ishigami K; Hirakawa M; Ushijima Y; Kakihara D; Nakayama T; Nishihara Y; Aishima S; Taketomi A; Kishimoto J; Honda H
    Eur J Radiol; 2012 Jun; 81(6):1116-21. PubMed ID: 21420813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retrospective audit to determine the diagnostic accuracy of Primovist-enhanced MRI in the detection of hepatocellular carcinoma in cirrhosis with explant histopathology correlation.
    Baird AJ; Amos GJ; Saad NF; Benson MD
    J Med Imaging Radiat Oncol; 2013 Jun; 57(3):314-20. PubMed ID: 23721140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Additional value of SPIO-enhanced MR imaging for the noninvasive imaging diagnosis of hepatocellular carcinoma in cirrhotic liver.
    Yoo HJ; Lee JM; Lee JY; Kim SH; Kim SJ; Han JK; Choi BI
    Invest Radiol; 2009 Dec; 44(12):800-7. PubMed ID: 19838119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of portal venous and delayed phases of gadolinium-enhanced magnetic resonance imaging study of cirrhotic liver for the detection of contrast washout of hypervascular hepatocellular carcinoma.
    Cereser L; Furlan A; Bagatto D; Girometti R; Como G; Avellini C; Orsaria M; Zuiani C; Bazzocchi M
    J Comput Assist Tomogr; 2010; 34(5):706-11. PubMed ID: 20861773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Additional value of gadoxetic acid-DTPA-enhanced hepatobiliary phase MR imaging in the diagnosis of early-stage hepatocellular carcinoma: comparison with dynamic triple-phase multidetector CT imaging.
    Haradome H; Grazioli L; Tinti R; Morone M; Motosugi U; Sano K; Ichikawa T; Kwee TC; Colagrande S
    J Magn Reson Imaging; 2011 Jul; 34(1):69-78. PubMed ID: 21598343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contrast-Enhanced Ultrasound (CEUS) for the characterization of focal liver lesions - prospective comparison in clinical practice: CEUS vs. CT (DEGUM multicenter trial). Parts of this manuscript were presented at the Ultrasound Dreiländertreffen 2008, Davos.
    Seitz K; Strobel D; Bernatik T; Blank W; Friedrich-Rust M; Herbay Av; Dietrich CF; Strunk H; Kratzer W; Schuler A
    Ultraschall Med; 2009 Aug; 30(4):383-9. PubMed ID: 19688670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of hepatocellular carcinoma in gadoxetic acid-enhanced MRI and diffusion-weighted MRI with respect to the severity of liver cirrhosis.
    Kim AY; Kim YK; Lee MW; Park MJ; Hwang J; Lee MH; Lee JW
    Acta Radiol; 2012 Oct; 53(8):830-8. PubMed ID: 22847903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gadoxetic acid-enhanced magnetic resonance imaging for differentiating small hepatocellular carcinomas (< or =2 cm in diameter) from arterial enhancing pseudolesions: special emphasis on hepatobiliary phase imaging.
    Sun HY; Lee JM; Shin CI; Lee DH; Moon SK; Kim KW; Han JK; Choi BI
    Invest Radiol; 2010 Feb; 45(2):96-103. PubMed ID: 20057319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Evaluation of noninvasive diagnostic criteria for hepatocellular carcinoma on pretransplant MRI (2010): correlation between MR imaging features and histological features on liver specimen].
    Ouedraogo W; Tran-Van Nhieu J; Baranes L; Lin SJ; Decaens T; Laurent A; Djabbari M; Pigneur F; Duvoux C; Kobeiter H; Deux JF; Rahmouni A; Luciani A
    J Radiol; 2011; 92(7-8):688-700. PubMed ID: 21819911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic performance of apparent diffusion coefficient for predicting histological grade of hepatocellular carcinoma.
    Nishie A; Tajima T; Asayama Y; Ishigami K; Kakihara D; Nakayama T; Takayama Y; Okamoto D; Fujita N; Taketomi A; Yoshimitsu K; Honda H
    Eur J Radiol; 2011 Nov; 80(2):e29-33. PubMed ID: 20619566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood oxygen level-dependent liver MRI: can it predict microvascular invasion in HCC?
    Jhaveri KS; Cleary SP; Fischer S; Haider MA; Pargoankar V; Khalidi K; Moshonov H; Gallinger S
    J Magn Reson Imaging; 2013 Mar; 37(3):692-9. PubMed ID: 23125092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histological characteristics of small hepatocellular carcinomas showing atypical enhancement patterns on gadoxetic acid-enhanced MR imaging.
    Choi YS; Rhee H; Choi JY; Chung YE; Park YN; Kim KW; Kim MJ
    J Magn Reson Imaging; 2013 Jun; 37(6):1384-91. PubMed ID: 23172629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatocellular Carcinoma: Retrospective Evaluation of the Correlation Between Gadobenate Dimeglumine-Enhanced Magnetic Resonance Imaging and Pathologic Grade.
    Huang X; Xiao Z; Zhang Y; Lin N; Xiong M; Huang X; Chen Q; Cao D
    J Comput Assist Tomogr; 2018; 42(3):365-372. PubMed ID: 29369947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MR imaging of hepatocellular carcinoma: relationship between lesion size and imaging findings, including signal intensity and dynamic enhancement patterns.
    van den Bos IC; Hussain SM; Dwarkasing RS; Hop WC; Zondervan PE; de Man RA; IJzermans JN; Walker CW; Krestin GP
    J Magn Reson Imaging; 2007 Dec; 26(6):1548-55. PubMed ID: 17968956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.